Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The PULSE PVC Registry Evaluates the Safety and Efficacy of Focal PFA Using the Centauri System for Symptomatic PVCs Across European Centers, With Outcomes Stratified by Site of Origin and Compared to Historical RF Ablation Data.

NCT07003412 is registered in ClinicalTrials.gov with Zentralklinik Bad Berka as lead sponsor.

NCT NCT07003412
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07003412 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The PULSE PVC Registry Evaluates the Safety and Efficacy of Focal PFA Using the Centauri System for Symptomatic PVCs Across European Centers, With Outcomes Stratified by Site of Origin and Compared to Historical RF Ablation Data.
Lead sponsor
Zentralklinik Bad Berka
Phase
Observational
Overall status
Completed
Start date
June 1, 2024
Completion date
September 1, 2026
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

premature ventricular contraction (pvc), pulsed field ablation